Your session is about to expire
← Back to Search
MOS Prebiotic for Gut Health in Healthy Older Adults
N/A
Waitlist Available
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days
Awards & highlights
Summary
This trial studies how baker's yeast-derived sugars can improve gut health and gut bacteria in older adults.
Who is the study for?
This trial is for healthy older adults aged 60-99 who can consent in English and are willing to follow the study procedures. It's not suitable for those with kidney disease, gastrointestinal surgeries or conditions, yeast allergies, current cancer treatment, recent antibiotic use, or if they're taking certain medications like laxatives.Check my eligibility
What is being tested?
The study is testing whether a yeast extract called Mannooligosaccharides (MOS) has prebiotic benefits that could improve gut function and alter fecal microbiota in older adults.See study design
What are the potential side effects?
Potential side effects may include changes in digestive functions such as bloating, gas, constipation or diarrhea due to the prebiotic nature of MOS affecting gut bacteria.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 14 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Mean daily rating of gastrointestinal symptoms
Trial Design
1Treatment groups
Experimental Treatment
Group I: MannooligosaccharidesExperimental Treatment1 Intervention
Mannooligosaccharides yeast extract
Find a Location
Who is running the clinical trial?
University of FloridaLead Sponsor
1,354 Previous Clinical Trials
713,324 Total Patients Enrolled
Lallemand Bio-IngredientsOTHER
3 Previous Clinical Trials
68 Total Patients Enrolled
Media Library
Research Study Groups:
This trial has the following groups:- Group 1: Mannooligosaccharides
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger